Geode Capital Management LLC Buys 9,500 Shares of Indivior PLC (NASDAQ:INDV)

Geode Capital Management LLC lifted its position in Indivior PLC (NASDAQ:INDV) by 7.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 132,239 shares of the company’s stock after buying an additional 9,500 shares during the quarter. Geode Capital Management LLC owned about 0.10% of Indivior worth $1,289,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in INDV. Public Employees Retirement System of Ohio acquired a new stake in Indivior in the third quarter valued at $294,000. XTX Topco Ltd lifted its stake in Indivior by 763.4% in the 3rd quarter. XTX Topco Ltd now owns 133,194 shares of the company’s stock valued at $1,299,000 after purchasing an additional 117,767 shares during the last quarter. Krensavage Asset Management LLC bought a new position in Indivior during the third quarter worth about $6,843,000. Jane Street Group LLC acquired a new position in Indivior during the third quarter worth approximately $180,000. Finally, Stifel Financial Corp bought a new stake in Indivior in the third quarter valued at approximately $100,000. 60.33% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

INDV has been the subject of several research analyst reports. Piper Sandler reiterated an “overweight” rating and set a $16.00 target price (up from $15.00) on shares of Indivior in a research note on Friday, October 25th. Craig Hallum decreased their price objective on shares of Indivior from $20.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, October 11th.

Indivior Price Performance

Shares of NASDAQ INDV opened at $12.09 on Friday. The business’s 50 day moving average is $11.23 and its 200-day moving average is $11.30. The firm has a market cap of $1.67 billion, a P/E ratio of -302.17 and a beta of 0.74. Indivior PLC has a 1-year low of $7.33 and a 1-year high of $23.22. The company has a current ratio of 0.83, a quick ratio of 0.65 and a debt-to-equity ratio of 23.50.

Indivior (NASDAQ:INDV) last announced its earnings results on Thursday, October 24th. The company reported $0.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.15. Indivior had a negative net margin of 0.17% and a negative return on equity of 351.08%. The company had revenue of $307.00 million during the quarter, compared to analysts’ expectations of $302.25 million. Equities research analysts predict that Indivior PLC will post 1.68 earnings per share for the current year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.